Anchors away: Contribution of a glycolipid anchor to bacterial invasion of host cells

Journal of Clinical Investigation

Volumn 115, Issue 9, 2005, Pages 2325-2327

  Baron, Miriam J ^a   Kasper, Dennis L ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOLIPID;

ANIMAL CELL; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BLOOD BRAIN BARRIER; CELL INTERACTION; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; GENE; HOST CELL; HUMAN; HUMAN CELL; IAGA GENE; LIPOGENESIS; MENINGITIS; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

BACTERIAL ADHESION; BACTERIAL PROTEINS; FEMALE; GLYCOLIPIDS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; INFANT, NEWBORN; MENINGITIS, BACTERIAL; STREPTOCOCCUS AGALACTIAE;

EID: 24644511609     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26285     Document Type: Review

References (22)

1. Cywes, C., and Wessels, M.R. 2001. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature. 414:648-652.
2. Tamura, G.S., Kuypers, J.M., Smith, S., Raff, H., and Rubens, C.E. 1994. Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect. Immun. 62:2450-2458.
3. Teti, G., Tomasello, F., Chiofalo, M.S., Orefici, G., and Mastroeni, P. 1987. Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect. Immun. 55:3057-3064.
4. Bulgakova, T.N., Grabovskaya, K.B., Ryc, M., and Jelinkova, J. 1986. The adhesin structures involved in the adherence of group B streptococci to human vaginal cells. Folia Microbiol. (Praha). 31:394-401.
5. Bolduc, G.R., Baron, M.J., Gravekamp, C., Lachenauer, C.S., and Madoff, L.C. 2002. The alpha C protein mediates internalization of group B Streptococcus within human cervical epithelial cells. Cell. Microbiol. 4:751-758.
6. Baron, M., Bolduc, G., Goldberg, M., Auperin, T., and Madoff, L. 2004. Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism. J. Biol. Chem. 279:24714-24723.
7. Doran, K.S., Chang, J. C., Benoit, V.M., Eckmann, L., and Nizet, V. 2002. Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J. Infect. Dis. 185:196-203.
8. Adderson, E., et al. 2003. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect. Immun. 71:6857-6863.
9. Schubert, A., et al. 2004. The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect. Immun. 72:6197-6205.
10. Gutekunst, H., Eikmanns, B., and Reinscheid, D. 2004. The novel fibrinogen-binding protein FbsB promotes Streptococcus agalactiae invasion into epithelial cells. Infect. Immun. 72:3495-3504.
11. Cheng, Q., et al. 2002. Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice. Infect. Immun. 70:6409-6415.
12. Marques, M.B., Kasper, D.L., Pangburn, M.K., and Wessels, M.R. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986-3993.
13. Edwards, M.S., Nicholson, W.A., Baker, C.J., and Kasper, D.L. 1980. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J. Exp. Med. 151:1275-1287.
14. Betz, A., and Goldstein, G. 1986. Specialized properties and solute transport in brain capillaries. Annu. Rev. Physiol. 48:241-250.
15. Doran, K.S., et al. 2005. Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J. Clin. Invest. 115:2499-2507. doi:10.1172/JCI23829.
16. Ring, A., Weiser, J., and Tuomanen, E. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Invest. 102:347-360.
17. Zaleznik, D., et al. 2000. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin. Infect. Dis. 30:276-281.
18. Lindblom, G., Brentel, I., Sjolund, M., Wikander, G., and Wieslander, A. 1986. Phase equilibria of membrane lipids from Acholeplasma laidlawii: importance of a single lipid forming nonlamellar phases. Biochemistry. 25:7502-7510.
19. Neuhaus, F.C., and Baddiley, J. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria [review]. Microbiol. Mol. Biol. Rev. 67:686-723.
20. Granlund, E.M., Sellin, M., Holm, A., and Hakansson, S. 1993. Adherence and surface properties of buoyant density subpopulations of group B streptococci, type III. APMIS. 101:141-148.
21. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
22. Kimpe, S.D., Kengatharan, M., Thiemermann, C., and Vane, J. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U. S. A. 92:10359-10363.